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Abstract
Enteric bacterial pathogens cause food borne disease, which constitutes an enormous economic and health burden.
Enterohemorrhagic Escherichia coli (EHEC) causes a severe bloody diarrhea following transmission to humans through
various means, including contaminated beef and vegetable products, water, or through contact with animals. EHEC also
causes a potentially fatal kidney disease (hemolytic uremic syndrome) for which there is no effective treatment or
prophylaxis. EHEC and other enteric pathogens (e.g., enteropathogenic E. coli (EPEC), Salmonella, Shigella, Yersinia) utilize a
type III secretion system (T3SS) to inject virulence proteins (effectors) into host cells. While it is known that T3SS effectors
subvert host cell function to promote diarrheal disease and bacterial transmission, in many cases, the mechanisms by which
these effectors bind to host proteins and disrupt the normal function of intestinal epithelial cells have not been completely
characterized. In this study, we present evidence that the E. coli O157:H7 nleH1 and nleH2 genes encode T3SS effectors that
bind to the human ribosomal protein S3 (RPS3), a subunit of nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-kB) transcriptional complexes. NleH1 and NleH2 co-localized with RPS3 in the cytoplasm, but not in cell nuclei. The N-
terminal region of both NleH1 and NleH2 was required for binding to the N-terminus of RPS3. NleH1 and NleH2 are
autophosphorylated Ser/Thr protein kinases, but their binding to RPS3 is independent of kinase activity. NleH1, but not
NleH2, reduced the nuclear abundance of RPS3 without altering the p50 or p65 NF-kB subunits or affecting the
phosphorylation state or abundance of the inhibitory NF-kB chaperone IkBa NleH1 repressed the transcription of a RPS3/
NF-kB-dependent reporter plasmid, but did not inhibit the transcription of RPS3-independent reporters. In contrast, NleH2
stimulated RPS3-dependent transcription, as well as an AP-1-dependent reporter. We identified a region of NleH1 (N40-K45)
that is at least partially responsible for the inhibitory activity of NleH1 toward RPS3. Deleting nleH1 from E. coli O157:H7
produced a hypervirulent phenotype in a gnotobiotic piglet model of Shiga toxin-producing E. coli infection. We suggest
that NleH may disrupt host innate immune responses by binding to a cofactor of host transcriptional complexes.
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Introduction
Diarrheal disease caused by enteric bacteria is an important
endemic health threat and a major source of food borne disease [1].
Over 76 million cases of diarrheal disease and 5,000 deaths result from
food borne illness in the United States annually (Centers for Disease
Control and Prevention). Diarrheagenic strains of E. coli contribute
greatly to the enormous economic and health burden of food borne
disease.Enteropathogenic E. coli (EPEC) isa frequent causeof infantile
diarrhea, while enterohemorrhagic E. coli (EHEC) has emerged as an
important cause of hemorrhagic colitis in developed countries [2].
Often transmitted to humans through consumption of fruit juice, raw/
undercooked meat, and vegetables contaminated with manure,
EHEC is especially important because it is the leading cause of
pediatric renal failure (hemolytic uremic syndrome; HUS).
EHEC adheres to intestinal enterocytes and produces a
characteristic attaching/effacing (A/E) lesion resulting from
localized intestinal microvilli destruction and the formation of a
pedestal-like projection composed of epithelial-derived cytoskeletal
components [3]. EHEC virulence proteins (effectors) are translo-
cated directly into intestinal epithelial cells through a type III
secretion system (T3SS; [4]). The T3SS is a molecular syringe,
widely conserved among animal and plant pathogens, that directs
the active transport of effectors into host cells. The EHEC T3SS
and several effectors are encoded on a pathogenicity island termed
the ‘locus of enterocyte effacement’ (LEE; [5]), whose genomic
structure, function, and regulation are well conserved among the
characterized A/E pathogens (i.e. EHEC, EPEC, Citrobacter
rodentium). Over 20 other secreted proteins (non-LEE-encoded
effectors; Nles) encoded by genes in multiple pathogenicity islands
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[6]. A bioinformatics study recently employed homology searches
against other bacterial effectors to identify 39 secreted/translocat-
ed effectors encoded in the EHEC Sakai genome [7]. Several
studies have reported the importance of Nles to virulence
[6,8,9,10,11,12,13,14].
Intestinal epithelial cells have evolved mechanisms to prevent
infection by pathogens by inhibiting bacterial colonization and by
interacting with the underlying immune system [15]. Paneth cells
located at the base of intestinal crypts produce proinflammatory
cytokines and express Toll-like receptors (TLRs) and nucleotide-
binding oligomerization domain (NOD) proteins. NOD proteins
recognize pathogen-associated molecular patterns (PAMPs) and
promote activation of host proinflammatory signaling pathways
[16], many of which are regulated by the nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-kB). PAMP detection
typically initiates a signal transduction cascade that promotes
polyubiquitination of the inhibitor of NF-kB( I kB)-kinase-c
complex (NEMO), ultimately leading to NF-kB activation through
the degradation of the inhibitory NF-kB chaperone IkBa.I kBa
masks the nuclear localization signal (NLS) of p65, yet leaves the
p50 nuclear localization signal exposed, permitting flux of IkBa/
NF-kB complexes between the nucleus and the cytoplasm [17].
IkBa degradation shifts the balance to favor increased nuclear
localization of NF-kB.
NF-kB homo- and hetero-dimers (typically composed of the p50
and p65 subunits) bind to DNA (kB sites) within target gene
promoters and regulate transcription by recruiting co-activator/
repressor molecules [18]. It is not completely clear how diverse
stimuli generate unique transcriptional responses in different cells
and tissues [19]. However, the recent discovery of a non-Rel
NF-kB subunit, RPS3, which guides NF-kB to specific kB sites
after specific cellular stimuli, has shed some light on this issue.
RPS3 was detected as a major co-purifying molecule with the p65
NF-kB subunit [18]. The N-terminal region of RPS3, notably the
KH domain, is required for binding to the N-terminal portion of
p65 [18]. RPS3 forms a complex with p65 that dramatically
increases the affinity of NF-kB complexes for a subset of target
genes and provides a mechanism by which selected promoters
could be activated in response to specific stimuli [18].
The identity and underlying mechanism of action of E. coli
PAMPs and effector proteins that respectively stimulate vs. repress
host innate immunity have been incompletely characterized. E. coli
flagellin induces secretion of interleukin (IL)-8 from intestinal
epithelial cells [20]. However, IL-8 secretion is inhibited relatively
early during infection by the delivery of one or more unidentified
T3SS effectors [20,21]. These effectors are believed to function by
preventing the degradation of IkBa, to reduce NF-kB transloca-
tion into the nucleus [20]. That the nuclear abundance of NF-kB
and its affinity for DNA are increased at early stages of infection,
without concomitant increases in IL-8 expression [20,22,23], may
also suggest effector-mediated inhibition of innate responses.
Despite significant effort, how T3SS effectors coordinate their
activities to suppress the potent host inflammatory response
normally induced by flagellin and other PAMPs remains
incompletely characterized.
E. coli O157:H7 EDL933 contains two copies of the nleH gene,
designated nleH1 (Z0989) and nleH2 (Z6021). Each gene encodes
predicted protein products with significant sequence similarity to
Shigella OspG [7,24,25], a protein known to interfere with NF-kB
activation [26]. C. rodentium, a pathogen of mice that shares many
pathogenic strategies with EHEC, rapidly induces the nuclear
translocation of NF-kB in host cells [27]. C. rodentium NleH has
been shown to play an important role in the colonization of animal
hosts and in altering NF-kB activity [25]. We therefore undertook
a biochemical analysis of the host binding partners and
mechanism of action of the E. coli O157:H7 effectors NleH1 and
NleH2 to understand better how bacterial effectors modulate host
innate immunity. In this study we show that the E. coli O157:H7
NleH proteins play an important role in host-pathogen interac-
tions by binding to the human ribosomal protein S3 (RPS3), a
newly identified subunit of NF-kB [18]. Our results suggest a
potentially novel mechanism for bacterial effector-mediated
disruption of host innate responses to infection.
Results
NleH1 and NleH2 are injected into host cells by the T3SS
Recent proteomic [6] and bioinformatic [7] screens identified a
repertoire of novel T3SS-effectors encoded on pathogenicity
islands throughout EHEC genomes in non-locus of enterocyte
effacement pathogenicity islands. Among these, E. coli O157:H7
strain EDL933 contains two copies of the nleH gene, designated
nleH1 (Z0989) and nleH2 (Z6021), which are predicted to encode
T3SS substrates [6]. NleH1 (293 amino acids) and NleH2 (303
amino acids) are 84% identical and encoded on distinct, non-LEE
pathogenicity islands (O-islands 36 and 71, respectively) from
which other T3SS-effectors with proven roles in bacterial
virulence (e.g. NleA, NleD) are expressed [11,14]. Others have
noted NleH sequence similarity to Shigella flexneri OspG and
serine/threonine protein kinases of Yersinia spp. [7].
Both NleH1 and NleH2 contain a lysine residue (K159 and
K169, respectively) present in a Ser/Thr protein kinase domain
that based on homology to Shigella OspG, may function as the
catalytic site of kinase activity. Despite 84% shared identity,
NleH1 differs from NleH2 in that NleH1 lacks a 10 amino acid
insertion containing putative SH2 and PKA-interaction domains
(Figure S1A). NleH1 also possesses several potential Ser/Thr
phosphorylation sites lacking in NleH2.
Other A/E pathogens also encode multiple copies of nleH. The
EHEC Sakai strain encodes nleH1 and nleH2 [7]. The recently
sequenced EPEC 2348/69 encodes three copies of nleH, one of
which may be a pseudogene [28]. nleH genes are present in other
EPEC genomes, including B171 [28] and E22 [29]. NleH1 and
NleH2 are also 83% identical to NleH encoded by C. rodentium
[25]. Only one copy of NleH is present in C. rodentium [24]. This
Author Summary
The nuclear factor kappa-light-chain-enhancer of activated
B cells (NF-kB) transcription factor complex plays an
essential role in regulating the immune response to
infection. Bacterial pathogens inject effector proteins into
host cells to modulate the host innate immune response
by interfering with NF-kB activation. We have discovered
that Escherichia coli O157:H7, an important cause of
hemorrhagic colitis, injects into mammalian cells an
effector protein termed NleH1, which inhibits NF-kB-
dependent transcription through a novel mechanism.
NleH1 binds directly to a subunit of NF-kB, the ribosomal
protein S3 (RPS3). One of the functions of RPS3 is to guide
the recruitment of the p65 NF-kB subunit to specific
promoters in response to different stimuli. NleH1, but not
a closely related effector, NleH2, functions by reducing the
nuclear abundance of RPS3 to dampen host transcriptional
outputs. Our findings highlight a previously unappreciated
mechanism by which bacterial effector proteins are able to
alter host cell functions.
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NleH2, as it lacks the 10 amino-acid insertion that is present in
EHEC NleH2, but absent in NleH1 [24].
To determine if EHEC NleH1 and/or NleH2 are translocated
into host cells by the E. coli T3SS, we constructed fusions to the
TEM-1 b-lactamase. This reporter system has proven robust for
assaying effector translocation into host cells [30]. These
constructs were introduced into both wild type and DescN EPEC,
a strain deficient in T3SS function that is commonly used to
evaluate the dependence of A/E pathogen effector translocation
on the T3SS. These strains were used to infect HeLa cells loaded
with the CCF2/AM substrate. We used a fluorescence microplate
reader to quantify b-lactamase activity in host cells after a 4 h
infection. While NleH1- and NleH2-TEM were expressed at
similar levels in both wild type and DescN EPEC (Figure S1B), the
proteins were detectably translocated into mammalian cells only
by wild type (p,0.001, ANOVA), indicating, as predicted from
studies of C. rodentium NleH [24], that both EHEC NleH1 and
NleH2 are translocated into host cells by the T3SS (Figure S1C).
To validate these data and begin to determine the subcellular
localization of NleH1 and NleH2, we constructed fusions to the
FLAG epitope in pFLAG-CTC, expressed these plasmids in
EHEC, and infected HeLa cells. After 4 h, we removed the
extracellular bacteria and subjected the cell lysates to immunoblot-
ting. Theexpected distributionof calnexin and tubulinvalidated the
integrity of membrane and cytoplasmic fractions, respectively.
NleH1 and NleH2 were detected in both the host cytoplasmic and
membrane fractions (Figure 1A). We obtained similar data after we
fractionated host cells infected with EPEC strains expressing FLAG
fusions to NleH1 and NleH2 (Figure S1D). We also employed
immunofluorescence microscopy to assess the intracellular locali-
zation of NleH1 and NleH2 by infecting HeLa cells with EHEC
strains expressing either NleH1 or NleH2 fused to the FLAG
epitope. NleH1 and NleH2 both localized to the cell periphery and
around, but not in, the host nucleus (Figure 1B).
NleH1 and NleH2 bind the human ribosomal protein S3
(RPS3)
To identify eukaryotic cell binding partners of NleH, we used
purified His-NleH1 to isolate mammalian proteins that bind to this
effector. We incubated His-NleH1 with HeLa cell lysates and
captured His-NleH1 and any co-purifying host proteins through
passage over Ni-NTA agarose resin (Figure S2A). Using mass
spectrometry, we identified a protein with an apparent molecular
mass of ,28 kDa that selectively eluted with NleH1 in affinity
purification experiments as RPS3, a nucleic acid-binding KH
domain protein implicated in DNA repair [31], and the regulation
of NF-kB-dependent transcription [18].
To verify that RPS3 interacts with NleH1 (Figure 2A), we used
an a-RPS3 antibody to immunoprecipitate RPS3 from cell lysates
obtained after infection with EPEC UMD207 [eae
-/bfp
-; [32]]
strains expressing FLAG-tagged NleH1, NleH2, or a control
FLAG epitope. We used this strain because it lacks both the
intimin protein and the bundle-forming pilus (BFP), thus
facilitating removal of the bacteria after infection, to reduce
potential contamination of translocated, immunoprecipitated
NleH with bacterial proteins. Both NleH1 and NleH2 co-
immunoprecipitated RPS3, supporting the affinity purification
data (Figure 2B). Likewise, immunoprecipitated RPS3 selectively
enriched for translocated NleH1 and NleH2 (Figure 2C).
To provide additional evidence for the specificity of NleH-RPS3
binding, we assessed the ability of NleH1 to bind to a different
ribosomal protein, RPS16. We determined that NleH1 did not
significantly bind to RPS16 (Figure S2B). Similarly, we assessed
the ability of a different EHEC effector protein, NleF [9], to
interact with RPS3. We determined that NleF could not effectively
immunoprecipitate RPS3 following its translocation into host cells
(Figure S2C).
RPS3 binds directly to the p65 NF-kB subunit [18]. We
therefore tested whether NleH associated with other NF-kB
proteins through RPS3 interaction. Immunoprecipitation of
NleH1 and NleH2 also enriched for the NF-kB subunits p50
and p65 (Figure 2D). We also performed experiments by depleting
RPS3 from cell lysates using an a-RPS3 antibody. When these
RPS3-depleted cell lysates were immunoprecipitated for NleH, we
were no longer able to detect either p50 or p65 (data not shown),
further substantiating that NleH interacts indirectly with NF-kB
via binding to RPS3.
Because of the homology between NleH and Shigella OspG, a
protein that binds ubiquitin-conjugating enzymes (E2s), including
UbcH5 and UbcH7 [26], we also tested if NleH interacted with
the host ubiquitin machinery. To do this we immunoprecipitated
NleH1 from cell lysates and performed immunoblotting experi-
ments to detect ubiquitination of NleH1 or its binding to Ub-
associated proteins. We did not obtain evidence of such
interactions (data not shown). Taken together, these biochemical
data suggest that NleH1 and NleH2 possess a novel host substrate,
RPS3, a protein that interacts with NF-kB to regulate mammalian
transcription.
BiFC analysis of NleH-RPS3 interaction
We next sought to confirm immunoprecipitation data with an
additional protein interaction assay, bimolecular fluorescence
complementation (BiFC). BiFC assays are based on the reconstitution
Figure 1. Translocation and localization of NleH1 and NleH2 in
host cells. A. Immunoblot analysis of cytoplasmic and membrane
HeLa cell fractions following infection with EHEC strains expressing
NleH1- or NleH2-FLAG fusions. Blots were probed with a-FLAG, a-
tubulin, and a-calnexin antibodies. B. Immunofluorescence microscopy
analysis of NleH localization. HeLa cells were infected with EHEC DescN
(left), EHEC/pnleH1-FLAG (middle), or EHEC/pnleH2-FLAG (right) and
stained with DAPI (blue) and an a-FLAG monoclonal antibody (green).
doi:10.1371/journal.ppat.1000708.g001
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when they are brought in close proximity by an interaction between
proteins fused to the YFP fragments (Figure 3A; [33,34]). Protein-
protein interactions generate a fluorescent signal at the site of the
protein complex, permitting quantification or direct visualization of
the interaction.
We based our design of NleH and RPS3 BiFC constructs on the
BiFC assay originally developed by Hu et al. [35,36]. This design
utilizes Venus, an enhanced yellow fluorescent protein (eYFP)
variant, which emits strong fluorescence [33] without requiring
significant protein over-expression [37]. We generated protein
chimeras with split N- and C-terminal fragments (VN and VC,
respectively), of eYFP. Then we designed plasmids to contain a
linker region between the eYFP fragment and a multi-cloning site.
HA epitope tags were added to facilitate detection with
immunoblotting. We also constructed fusions to actin, a protein
often used as a positive control in BiFC assays, as well as fusions to
RPS3 and NleH1 and NleH2 (Figure 3B). These constructs were
transfected into HeLa cells and analyzed 48 h post-transfection.
The reconstitution of eYFP mediated by interaction between
the N- and C-termini of actin generated intense fluorescence
(Figure 3C). In contrast, the expression of individual constructs or
constructs lacking both actin fragments did not generate significant
fluorescence. We then examined the potential for interaction
between RPS3 and NleH1 or NleH2. The co-expression of eYFP
chimeras of RPS3 and both NleH1 and NleH2 also reconstituted
YFP fluorescence (p,0.001, ANOVA), whereas transfection of
individual plasmids did not (Figure 3C), suggesting that both
NleH1 and NleH2 bind RPS3 in mammalian cells. Similar data
were obtained irrespective of the position of the eYFP fusion
relative to NleH or RPS3 (e.g. compare Figure 3C, lanes G–H
and K–L). In addition, we used confocal immunofluorescence
microscopy after infecting cells with EPEC strains expressing
NleH1- or NleH2-FLAG to determine that both NleH1 and
NleH2 co-localize with endogenous RPS3 in the cytoplasm
(Figure 3D). These microscopy data support the previously
described biochemical analyses that showed an interaction
between NleH and RPS3.
NleH N-termini bind to the N-terminus of RPS3
To map the binding domain of RPS3 on NleH1 and NleH2, we
carried out a structure-function study with deletions of RPS3 that
encompass the known functional domains of this protein
(Figure 4A). Co-immunoprecipitation experiments revealed that
the region of RPS3 (AAs 1–41) N-terminal to the KH domain is
required for RPS3 binding to both NleH1 and NleH2 (Figure 4B).
A similar analysis revealed that the N-termini of NleH1 and
NleH2 (AAs 1–139 and 1–149, respectively) were required for
binding to RPS3 (Figure 4C).
NleH1 and NleH2 are autophosphorylated Ser/Thr
protein kinases
Given the sequence conservation between NleH and a domain
implicated in the autophosphorylation and kinase activities of
Shigella OspG [7,26], we examined if NleH1 and NleH2 are also
Ser/Thr protein kinases. We purified His-NleH1 and NleH2, as
well as NleH site-directed mutants in which a lysine residue was
mutated to alanine [NleH1(K159A) and NleH2(K169A)]. By
performing Pro-Q staining of purified proteins, we determined
that, similar to OspG [26], both NleH1 and NleH2 are
autophosphorylated (Figure S3A). We also used these proteins to
assay for phosphorylation of the myelin basic protein (MBP), a
commonly used substrate in protein phosphorylation assays. Both
wild-type NleH1 and NleH2, but not the site directed mutants
[NleH1(K159A) or NleH2(K169A)], phosphorylated MBP in vitro
(Figure S3B), suggesting that NleH1 and NleH2 possess kinase
activity.
RPS3 is phosphorylated by the extracellular signal-regulated
kinase 1 (ERK1) on T42 [38]. This event is necessary for RPS3
nuclear translocation in response to DNA damage [39] and may
play a role in the transcriptional activities of RPS3 [18]. The non-
ribosomal fraction of RPS3 is also phosphorylated by PKCd on S6
and T221 to promote its nuclear translocation [40]. To determine
if NleH kinase activity is essential to RPS3 binding, we
immunoprecipitated RPS3 and interrogated the samples for the
presence of wild type or kinase-deficient NleH1/NleH2. We
observed that NleH-RPS3 binding was independent of NleH
kinase activity (Figure 4D).
Figure 2. NleH1 and NleH2 bind to the host ribosomal protein
S3 (RPS3). A. RPS3 amino acid sequence. Tryptic peptides identified
by mass spectrometry are indicated in red. B. Immunoprecipitation of
RPS3 from HeLa cells by translocated NleH1- and NleH2-FLAG following
infection with EPEC UMD207. Samples were immunoprecipitated with
a-FLAG antibody and immunoblotted for RPS3. The lower panel
indicates the RPS3 abundance in the cell lysates. C. Immunoprecipita-
tion of NleH1- and NleH2-FLAG from HeLa cells by RPS3 following
infection with EPEC UMD207. Samples were immunoprecipitated with
a-RPS3 antibody and immunoblotted for FLAG to detect NleH. The
lower panel demonstrates the equal enrichment of RPS3 among
samples following a-RPS3 immunoprecipitation. D. Enrichment of the
p50 and p65 NF-kB subunits by NleH1 and NleH2. Samples were
immunoprecipitated with a-FLAG antibody and immunoblotted for p50
(top) and p65 (bottom).
doi:10.1371/journal.ppat.1000708.g002
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in vitro kinase assays with NleH and RPR3 and analyzed the results
by immunoblotting with an a-phospho-Ser/Thr-specific antibody
(the utility of which for RPS3 phosphorylation studies has been
documented previously [40]), following separation by SDS-PAGE.
We determined that while NleH1 and NleH2 could phosphorylate
MBP, and ERK1 could phosphorylate RPS3, NleH1 and NleH2
had no detectable ability to phosphorylate RPS3 (data not shown).
Overall, these data suggest that the NleH-RPS3 interaction is
independent of NleH kinase activity. Further, they leave open the
possibility that NleH effectors may be multifunctional proteins
with the capacity to target multiple host regulatory pathways.
NleH1 reduces the nuclear abundance of RPS3
RPS3 translocates to the nucleus after stimulation with tumor
necrosis factor-alpha (TNF-a)[ 1 8 ] .N l e H 1a n dN l e H 2b i n dt ot h eN -
terminus of RPS3, potentially masking its putative nuclear localization
signal. To determine if NleH bindingt oR P S 3i n h i b i t st r a n s l o c a t i o no f
RPS3 into the nucleus, we first used immunofluorescence microscopy
to evaluate the relative abundance of nuclear vs. cytoplasmic RPS3.
The percentage of cells containing predominantly nuclear RPS3 was
significantly reduced in cells infected with wild type (863%) vs. DescN
EHEC (36610%; p=0.01, t-test), suggesting an EHEC T3SS effector
alters RPS3 nuclear abundance (Figure S4A-B).
We evaluated the relative abundance of nuclear vs. cytoplasmic
RPS3 in 293T cells in the presence or absence of transfected
NleH1- and NleH2-HA with or without 1 h stimulation with
100 ng/ml TNF-a. We subsequently fractionated the cells to
separate nuclear from cytoplasmic components. We quantified
poly(ADP-ribose) polymerase (PARP) and tubulin abundance to
normalize the concentrations of nuclear and cytoplasmic subcel-
lular protein fractions. The lack of PARP in the cytoplasmic
fraction and the lack of tubulin in the nuclear fraction
demonstrated the absence of cross-contamination between the
fractions (Figure 5A). As expected from previous reports utilizing
similar treatment conditions [18], the nuclear abundance of
both RPS3 and p65 significantly increased after stimulation with
TNF-a. Most notably, the nuclear abundance of RPS3 was
significantly reduced in samples containing NleH1, while nuclear
p65 and cytoplasmic concentrations of both RPS3 and p65 were
unchanged. NleH1 and NleH2 were expressed equally among all
samples, but were detected only in the cytoplasm, rather than the
nuclear fraction (Figure 5A), consistent with immunofluorescence
microscopy data.
Quantitative analysis of RPS3 abundance (based on densitom-
etry analysis of immunoblots) revealed that NleH1 significantly
reduced (,65%) the relative abundance of nuclear RPS3
(Figure 5B, p,0.001, ANOVA) after stimulation with TNF-a.
Figure 3. Bimolecular fluorescence complementation analysis of NleH-RPS3 interaction. A. BiFC schematic. Protein-protein interaction
promotes the reconstitution of a functional fluorophore, measured as an increase in the YFP:CFP emission ratio [33,34]. B. Experimental design of
NleH- and RPS3-eYFP fusions. VN, N-terminus (AAs 1–173) of Venus fluorescence protein; VC, C-terminus (AAs 155–238) of Venus fluorescence
protein. C. Relative fluorescence intensity resulting from the co-transfection of the indicated NleH- and RPS3-eYFP plasmid combinations (n=3).
Asterisks indicate significantly different fluorescence intensity compared with uninfected samples (p,0.05, ANOVA). D. Confocal immunofluores-
cence microscopy analysis of NleH and RPS3 co-localization. HeLa cells were infected with EPEC strains expressing NleH1- or NleH2-FLAG and stained
with DAPI (blue), a-FLAG (green), and a-RPS3 (red) antibodies. Two representative cells are shown for each infection condition.
doi:10.1371/journal.ppat.1000708.g003
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nuclear abundance. Neither protein altered the nuclear abun-
dance of the NF-kB p65 subunit (Figure S5A). The nuclear
abundance of p50 was also unchanged as a function of NleH
expression (data not shown), indicating that NleH1 activity is
specific to RPS3. The kinase activity of NleH1 was important for
its ability to reduce RPS3 nuclear abundance, as the effect of
transfecting NleH1(K159A) was not significantly different from
that of transfecting the HA control plasmid (Figure 5B).
Immunofluorescence microscopy analyses support these bio-
chemical data. We observed that RPS3 translocated into the
nuclei of HeLa cells after TNF-a stimulation. The nuclear
translocation of RPS3 was inhibited in cells infected with EPEC
expressing NleH1-FLAG, but not NleH2-FLAG, relative to
uninfected controls (Figure S5B). We also used an a-p65 antibody
for immunoprecipitation of nuclear extracts to validate further that
the impact of NleH1 on reducing RPS3 nuclear abundance would
alter the nuclear association of RPS3 with p65. Our analysis of
immunoprecipitated nuclear p65 samples indicated a reduced
abundance of RPS3 in samples co-transfected with NleH1, but not
NleH2, relative to an HA epitope control (Figure S5C), also
suggesting that NleH1 could interfere with RPS3-p65 interactions
by reducing RPS3 nuclear abundance.
To test further the hypothesis that NleH1 reduces RPS3 nuclear
abundance, we also quantified changes in nuclear RPS3 after
infecting HeLa cells with EHEC strains possessing or lacking nleH1
and/or nleH2 constructed using lambda Red mutagenesis [41].
After 3 h of infection, bacteria were killed with antibiotics and
TNF-a was added at 100 ng/ml for 1 h to stimulate RPS3 nuclear
translocation. Infection with DnleH1 EHEC failed to inhibit RPS3
nuclear translocation, whereas infection with DnleH2 was not
significantly different from wild type EHEC (Figure 5C). Our
analysis of the DnleH1DnleH2 mutant also indicated that NleH1 is
the EHEC effector primarily responsible for reducing the nuclear
abundance of RPS3. Complementing nleH mutants with corre-
sponding NleH-FLAG plasmids confirmed the dependence of
alterations in RPS3 nuclear abundance upon NleH1 (Figure 5C).
Neither NleH1 nor NleH2 impaired the TNF-a or phorbol 12-
myristate 13-acetate (PMA)-induced phosphorylation of IkBa, nor
did they alter total IkBa concentrations (Figure 5D), suggesting
that unlike OspG [26], NleH1 and NleH2 do not alter the
degradation of the inhibitory IkBa subunit. Overall, these data
support a role for NleH1, but not NleH2, in the reduction of RPS3
nuclear abundance, without significant impact on other NF-kB
subunits. While the NleH1 K159 residue was non-essential for
RPS3 binding, it was important to the ability of NleH1 to reduce
RPS3 nuclear abundance, suggesting that other host proteins or
translocated effectors may be involved.
Functional differences between NleH1 and NleH2
Because our binding studies suggested that both NleH1 and
NleH2 bind to RPS3, we were somewhat surprised to observe that
only NleH1, and not NleH2, reduced RPS3 nuclear abundance.
To begin to elucidate the functional differences between these two
effectors, we sought to generate and characterize mutations in
NleH1 that would still be competent for RPS3 binding, yet would
Figure 4. N-termini of NleH1 and NleH2 bind to the N-terminus of RPS3. A. Design of RPS3 and NleH protein truncations. The amino acids
present in each truncation are indicated to the left of the figure. The death (pink), KH (green), and DNA-repair (blue) domains of RPS3 are indicated.
The white box depicts the 10 amino acids lacking in NleH1 but present in NleH2. B. Co-immunoprecipitation of NleH1- (top) and NleH2-HA (middle)
with RPS3-FLAG truncations. Samples were immunoprecipitated with a-FLAG antibody to capture RPS3 and immunoblotted for HA to detect NleH.
The bottom panel depicts the expression levels of the RPS3-FLAG truncations. C. Co-immunoprecipitation of RPS3-FLAG with NleH1- and NleH2-HA
truncations. Samples were immunoprecipitated with a-HA antibody to capture NleH and immunoblotted for FLAG to detect RPS3. The lower panel
depicts the expression levels of the NleH truncations. D. Immunoprecipitation of RPS3-FLAG with NleH1(K159A)-HA and NleH2(K169A)-HA. Samples
were immunoprecipitated with a-HA antibody to capture NleH and immunoblotted for FLAG to detect RPS3. The lower panel depicts the expression
levels of RPS3 in cell lysates.
doi:10.1371/journal.ppat.1000708.g004
NleH Binds Ribosomal Protein S3
PLoS Pathogens | www.plospathogens.org 6 December 2009 | Volume 5 | Issue 12 | e1000708Figure 5. NleH1 reduces the nuclear abundance of RPS3. A. Immunoblot analysis of cytoplasmic and nuclear fractions of 293T cells
transfected with NleH1, NleH2, or an HA-epitope control, in the presence or absence of TNF-a (100 ng/ml) stimulation for 1 h. Blots were probed with
a-RPS3, a-p65, a-HA, a-tubulin, and a-PARP monoclonal antibodies. B. Quantification (n$4) of the fold-increase in nuclear RPS3 as assessed by
densitometry analysis of immunoblots in the absence (open bars) or presence (black bars) of TNF-a stimulation. RPS3 signal intensity was normalized
to tubulin (cytoplasmic) and PARP (nuclear). Asterisks indicate significantly different compared with HA transfection (p,0.05, ANOVA). C.
Quantification of the fold-increase in nuclear RPS3 following a 3 h infection of HeLa cells with E. coli O157:H7 EDL933 strains possessing or lacking
nleH1 and/or nleH2, as well as with strains complemented with the indicated NleH plasmids (n=3). Asterisks indicate significantly different compared
with wild-type infection (p,0.05, ANOVA). D. Immunoblot analysis of IkBa phosphorylation induced by TNF-a (left) or PMA (right), and total IkBa,i n
the presence or absence of NleH. E. Immunoblot analysis of the impact of C. rodentium NleH and EHEC NleH1 truncations and site-directed mutants
on RPS3 nuclear abundance. Blots were probed with a-HA (top), a-RPS (middle), and a-PARP (bottom) monoclonal antibodies. The HA-input panel
depicts the expression levels of the indicated constructs. The a-RPS panel depicts the nuclear abundance of RPS3 after stimulation with TNF-a in 293T
cells transfected with the indicated constructs. The a-PARP signal was used for normalization of immunoblot signal intensities. F. Quantification
(n=3) of the fold-increase in nuclear RPS3 as assessed by immunoblotting in the presence of the indicated NleH expression plasmids. Asterisks
indicate significantly different compared with NleH1 transfection (p,0.05, ANOVA).
doi:10.1371/journal.ppat.1000708.g005
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NleH binding to RPS3 is mediated by the N-terminus, we targeted
this region for mutagenesis and focused on several amino acids
that differ between NleH1 and NleH2.
We first confirmed that C. rodentium NleH, which appears to be
more similar to EHEC NleH1 than NleH2, also reduced RPS3
nuclear abundance (Figure 5E–F). By transfecting individually the N-
(AAs 1–129) and C-terminal (AAs 130–293) regions of NleH1, we also
determined that the N-terminus of NleH1 was sufficient to reduce
RPS3 nuclear abundance. We then constructed NleH1 mutants in
which residues of NleH1 were swapped for those appearing in NleH2.
These point mutants (Y5S; N40S,A42T,K45T; and A100T,A101T,-
M102I,I106S) were expressed at similar levels as wild type NleH1 and
were able to bind RPS3 (Figure 5E and S5D). We determined that
mutating the N40,A42,K45 region of NleH1 to S40,T42,T45 was
sufficient to prevent the NleH1-mediated inhibition of RPS3 nuclear
abundance (Figure 5E–F). Mutating the A100,A101,M102,I106
region had a modest, but statistically insignificant influence on NleH1
activity, whereas we found that mutating Y5 had no impact on NleH1
activity. Since C. rodentium NleH appears to have similar activity to
EHEC NleH1, modulating RPS3 dynamics may be a strategy
employed by multiple A/E pathogens.
NleH1 and NleH2 differentially regulate
NF-kB-dependent transcriptional activity
After translocating into the nucleus, RPS3 selectively alters the
expression of a subset of kB-dependent gene promoters to generate
specific transcriptional responses to diverse extracellular signals
[18]. p65 binding to kB sites in IkBa, IL-8, and IL-2 promoters is
significantly reduced in RPS3-knockdown cells [18], whereas
RPS3-independent genes (e.g. CD25 and CD69) are unaffected.
This observation suggests that selective gene expression is due to
differing requirements of specific promoter sites for the RPS3
subunit of NF-kB. Because NleH1 and NleH2 bind to RPS3, with
NleH1 reducing its nuclear abundance, and because RPS3
regulates NF-kB activity, we hypothesized that NleH1 and/or
NleH2 might also alter NF-kB dependent transcription.
To test this hypothesis, we co-transfected HeLa cells with a
firefly luciferase construct driven by a consensus kB site previously
demonstrated to be responsive to RPS3 [18], to measure NF-kB
activity. For data normalization, we used a renilla luciferase
plasmid. We quantified luciferase activity and then calculated the
fold-induction of NF-kB activity relative to unstimulated or
uninfected cells.
Treating cells with TNF-a stimulated NF-kB-dependent
luciferase activity ,12-fold (Figure 6A). Transfecting RPS3 siRNA
reduced RPS3 protein abundance to ,20% of native levels
(Figure S6A) and reduced the effect of TNF-a stimulation ,4-fold
(Figures 6A and S6B), confirming the sensitivity of the luciferase
assay and importantly, the significant dependence upon RPS3 for
efficient NF-kB transcription from this kB site ([18]; Figure 6A).
We infected HeLa cells with wild type and T3SS-deficient DescN
EHEC. Our findings confirmed previous observations that T3SS
effectors inhibit NF-kB (Figure 6A, p,0.001, ANOVA; [20]). We
discovered that deleting nleH1, but not nleH2, prevented EHEC
from suppressing NF-kB activity (p=0.002), indicating that NleH1
inhibits NF-kB-dependent transcription. By complementing the
nleH mutants with corresponding NleH-FLAG plasmids, we also
confirmed the dependence of alterations in RPS3/NF-kB-
dependent luciferase activity upon NleH (Figure 6A).
We obtained similar data after transfecting 293T cells with
NleH1 and NleH2 and stimulating these cells with TNF-a.B y
transfecting nleH1, we were able to inhibit NF-kB activity to
,45% of native levels (Figure 6B; p,0.001, ANOVA). In
contrast, transfecting nleH2 stimulated NF-kB activity by ,20%.
We observed the differential activity of NleH1 vs. NleH2 even
after we introduced additional RPS3 via transfection of RPS3-
FLAG (Figure S6C). This activity was also dose-dependent with
respect to the amount of transfected NleH (Figure S6D). By
mutating the NleH1 K159 residue to alanine [NleH1(K159)], we
eliminated NleH1-mediated NF-kB inhibition (Figure 6B).
Furthermore, neither NleH1 nor NleH2 altered CD25- or
IL-2R-dependent luciferase expression. As these reporters are
known to be RPS3-independent [18], these results further
demonstrate the specificity of NleH for RPS3 (Figure 6C).
Transfecting NleH2 increased the activity of an AP-1-dependent
luciferase reporter, suggesting a potential target for this effector.
To extend our findings and to confirm that that activity of
NleH1 is restricted to specific RPS3/NF-kB promoters, we
performed RT-PCR to assess NleH regulation of several genes
(IL-8, NFKBIA [42], and TNFIAP3 [43]) that are important to
the innate response to infection and whose transcription is altered
by rps3 knockdown [18]. IL-8 gene transcription was activated by
infection with wild-type EHEC, as expected [20,21]. This
activation was further increased after infecting cells with either
DescN or DnleH1, but not DnleH2, indicating that a T3SS effector
[20,21], most likely NleH1, inhibits IL-8 transcription (Figure 6D).
Additionally, transcription of both the NFKBIA and TNFIAP3
genes were upregulated more in DescN and DnleH1, compared with
wild-type and DnleH2 infections, also suggesting a role for NleH1
in transcriptional inhibition of these RPS3-dependent genes.
To confirm further the role of NleH1 in inhibiting RPS3-
dependent gene expression, we also performed transfection
experiments. Transfecting rps3 siRNA into 293T cells inhibited
IL-8 expression ,4.5-fold (Figure 6E). Transfecting NleH1, but
not NleH2 reproduced this phenotype. The transcription of both
PLK1 and CENPE, two genes involved in NF-kB activation [44],
was also inhibited by rps3 knockdown and by NleH1, but not by a
sequence-scrambled siRNA or by NleH2. In contrast, transcrip-
tion of IRF4, an RPS3-indepenent gene [18], was unaffected.
Overall, these infection and transfection experiments suggest that
NleH1 specifically inhibits RPS3-dependent gene expression.
We also analyzed site-directed NleH1 mutants to extend our
findings that suggest NleH1 and NleH2 have differential influence on
NF-kB activity. Similar to RPS3 nuclear abundance data obtained
after transfection with different NleH1 point mutants (Figure 5E–F),
co-transfecting NleH1(N40S,A42T,K45T) abolished NleH1 inhibitory
activity, whereas mutating either the Y5 or the A100,A101,M102,I106
region did not prevent NleH1 from inhibiting NF-kB( F i g u r e6 F ) .
We wished to determine the extent to which NleH1 and NleH2
are conserved among other A/E pathogens. We first noted that C.
rodentium NleH was also able to reduce RPS3 nuclear abundance
(Figure 5E–F) and to inhibit RPS3/NF-kB luciferase activity
(Figure 6B). We cloned nleH from other O157:H7 and O88:H25
strains and tested their ability to inhibit RPS3/NF-kB luciferase
activity by transfecting them into 293T cells (Figure S7). NleH
cloned from other O157:H7 inhibited NF-kB activity to the same
magnitude as EDL933 NleH1 (92–96% of EDL933 activity; data
not shown). NleH cloned from O88:H25 strains also inhibited NF-
kB activity, but to a lesser extent (74–78% of EDL933). Overall,
these data demonstrate that NleH-mediated inhibition of RPS3/
NF-kB transcriptional activity is not restricted to EDL933, but
rather is conserved in non-O157 STEC and in C. rodentium.
E. coli O157:H7 DnleH1 is hypervirulent in gnotobiotic
piglets
The 1-day-old gnotobiotic pig is a robust model organism for
studying human EHEC disease [45]. Piglets challenged with
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PLoS Pathogens | www.plospathogens.org 8 December 2009 | Volume 5 | Issue 12 | e1000708Figure 6. NleH effectors alter host NF-kB activity. A. Relative NF-kB activity (compared with uninfected cells) as a function of TNF-a stimulation,
siRNA transfection, and/or infection with EHEC strains possessing or lacking nleH1 and/or nleH2 (n$4). HeLa cells were co-transfected with a firefly
luciferase construct driven by a consensus kB site and a renilla luciferase plasmid, cultured for 36 h, and then infected with EHEC strains for 3 h in the
presence or absence of TNF-a stimulation or silencing with rps3 siRNA. Asterisks indicate significantly different compared with wild-type infection
(p,0.05, ANOVA). B. Relative NF-kB activity in 293T cells transfected with the indicated NleH plasmids (n=4). After 36 h, cells were stimulated with
TNF-a (100 ng/ml, 1 h). Asterisks indicate significantly different compared with HA transfection (p,0.05, ANOVA). C. Impact of NleH1 and NleH2 on
CD25 (left), IL-2R (middle), and AP-1 (right)-dependent luciferase reporter activity. 293T cells were transfected with the indicated reporter plasmids
and treated with either TNF-a (CD-25 and IL-2R) or PMA (AP-1) 36 h post-transfection (n=3). Asterisks indicate significantly different compared with
HA transfection (p,0.05, ANOVA). D. Relative transcript abundance, relative to uninfected cells assessed by RT-PCR analysis of 293T cells infected for
4 h with the indicated bacterial strains. IL-8, NFKBIA, and TNFIAP3 data were normalized to GAPDH expression. E. Relative transcript abundance in
293T cells after 48 h transfection with HA, NleH1-HA, NleH2-HA, and RPS3-specific or sequence-scrambled (ns) siRNA constructs. IL-8, PLK1, CENPE,
and IRF4 data were normalized to GAPDH expression. F. Impact of C. rodentium NleH and EHEC NleH1 truncations and site-directed mutants on RPS3/
NF-kB-dependent transcriptional activity. Experiments were performed as described in panel B, using the plasmids indicated on the x-axis (n=3).
Asterisks indicate significantly different compared with NleH1 transfection (p,0.05, ANOVA).
doi:10.1371/journal.ppat.1000708.g006
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attachment to the mucosal surfaces of the terminal ileum and
large bowel. Infected piglets also develop fatal central nervous
system (CNS) disease several days after inoculation [46], an
important, yet underappreciated side effect of hemolytic uremic
syndrome (HUS; [47]). Anatomically and physiologically similar to
human children, piglets develop CNS symptoms and intestinal
lesions develop over a similar time course following the onset of
diarrhea [48]. EHEC infection of gnotobiotic piglets can be used
to evaluate the contribution of virulence factors to host
colonization and disease [9,45].
To measure the contribution of NleH1 and NleH2 to EHEC
virulence in vivo, we orally infected gnotobiotic piglets at 24 h of
age with 2*10
8 CFUs of wild type EHEC EDL933, DnleH1,o r
DnleH2 (n=526/group). Piglets were observed every 4 h for signs
of diarrhea, dehydration, and neurological signs of disease. Piglets
infected with wild-type EHEC succumbed to infection over a
,7-day period (Figure 7A, filled circles). Piglets infected with
DnleH1 (open circles), but not DnleH2 (open squares), died more
rapidly (Figure 7A; p=0.004, Kruskal-Wallis test). DnleH1 induced
rapid and severe clinical signs of disease consistent with an
inflammatory response (Figure 7B, left; p=0.02), yet caused little
diarrhea (Figure 7B, right; p=0.01) and displayed significantly
reduced colonization (Figure 7C; p=0.001). In contrast, DnleH2
had no effect on clinical outcome, though colonization of the piglet
colon was reduced ,10-fold.
Discussion
PAMP recognition by TLRs transduces signals that activate and
bind NF-kB to DNA (kB sites) within target gene promoters to
regulate transcription by recruiting co-activators or co-repressors
[18]. Activation typically proceeds via degradation of the
inhibitory NF-kB chaperone IkBa, favoring the nuclear localiza-
tion of NF-kB. Bacterial pathogens inject effector proteins into
host cells to inhibit the innate immune response by interfering with
NF-kB activation [49]. For example, Shigella OspG is a protein
kinase that binds to ubiquitinylated ubiquitin-conjugating enzymes
(E2s) to block degradation of IkBa, an event that ultimately
inhibits NF-kB activity [26]. OspF is a phosphatase that targets
MAPKs to prevent histone phosphorylation and dampen tran-
scription at NF-kB-dependent promoters [50]. OspB and OspF
also interact with the retinoblastoma protein, possibly to facilitate
chromatin remodelling and diminish inflammatory cytokine
production [51]. Yersinia YopJ inhibits the NF-kB pathway by
inhibiting MAPKKs [52]. The Salmonella SseL effector is a
deubiquitinating enzyme that impairs IkBa ubiquitination and
degradation, thus reducing the production of NF-kB-dependent
cytokines [53]. Mice lacking the p50 subunit of NF-kB (p50
2/2)
do not clear a C. rodentium infection within the duration of the
experiment [54], indicating a critical role for NF-kB in host-
defense against A/E pathogens. While the details have yet to be
unravelled completely, EHEC T3SS effectors are suggested as key
factors for bacterial inhibition of the host immune response [20].
Over a dozen ribosomal proteins that play significant roles in
gene-specific transcriptional and translational regulation have
been described (reviewed in [55,56]). For example, RPL7 binds
the Vitamin D receptor to regulate gene transcription [57]. Both
RPL23 and RPS9 interact with the nucleolar chaperone protein
B23. B23, also termed NPM/nucleophosmin/NO38, is a cofactor
of the zinc-finger protein Miz1, a regulator of cell proliferation
[55,58]. RPL11 binds directly to Myc and inhibits its transcrip-
tional activation activity [59]. Thus, the idea that ribosomal
proteins also function in the nucleus to regulate transcription is
well established, although until now, the targeting of these proteins
by bacterial pathogens to subvert host cell functions was not.
By using several protein-interaction technologies, we deter-
mined that the translocated EHEC effectors NleH1 and NleH2
bind directly to the NF-kB non-Rel subunit, RPS3. NleH1 and
NleH2 both interact with RPS3 through the binding of their N-
termini to the N-terminal region of RPS3 that contains a putative
nuclear localization signal (NLS). NleH1, but not NleH2,
significantly reduced the nuclear abundance of RPS3, but had
little influence upon other NF-kB subunits (e.g. p50 or p65). Using
site-directed mutagenesis, we characterized a region of NleH1
(N40-K45) that is at least partially responsible for the inhibitory
activity of this protein toward RPS3. By cloning and transfecting
nleH from other O157 and non-O157 STEC, we demonstrated
that NleH1 is present in other strains of significance to human
health.
Although NleH1 and NleH2 are autophosphorylated proteins
with Ser/Thr protein kinase activity, neither protein appeared to
have the ability to phosphorylate RPS3. While the NleH1 K159
residue was non-essential for RPS3 binding, it was important
to the ability of NleH1 to reduce RPS3 nuclear abundance,
leaving open the possibility that other host proteins or trans-
located effectors may also be involved. Surprisingly, both the full-
length and the isolated N-terminus of NleH1 (residues 1–139)
inhibited RPS3 nuclear localization, while full-length NleH1
Figure 7. E. coli O157:H7 DnleH1 is hypervirulent in gnotobiotic piglets. A. Survival analysis of gnotobiotic piglets as a function of time post-
inoculation with EHEC strains possessing or lacking nleH1 or nleH2. B. Quantification of piglet clinical outcome (left) and extent of diarrheal disease
following EHEC challenge (right). C. Quantification of EHEC colonization of piglet colonic tissue (CFUs/g colon).
doi:10.1371/journal.ppat.1000708.g007
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may target another host protein with a role in RPS3 translocation,
suggesting that NleH may be a multi-functional protein. We
speculate that the K159A mutant may have an altered structure or
have reduced ability to bind other cellular factors that affect RPS3
activities.
Others [24] and we have shown that NleH localizes to both host
membranes and the cytosol following translocation. It is possible
that the subcellular distribution of NleH may change to associate
with the non-ribosomal pool of RPS3. It will be interesting to
determine if mutating K159 somehow inhibits the ability of NleH
to interact with a host protein needed for enrichment into the
cytosol, a requirement that the isolated NleH N-terminus may
not face.
The cellular factors governing the nuclear import of RPS3 are
not completely understood. Its nuclear entry is thought to depend
upon the phosphorylation of the T42 residue by the extracellular
signal-regulated kinase (ERK) [38,39]. However, other reports
suggest that PKCd phosphorylates RPS3 on S6 and T221,
resulting in RPS3 nuclear mobilization to participate in DNA
repair activities [40]. Furthermore, the role of RPS3 phosphor-
ylation in its interaction with NF-kB has not yet been studied in
detail [18]. As EPEC T3SS effectors have been shown to inhibit
the phosphorylation-associated activation of ERK and p38 MAPK
pathways [20], it will be of interest to learn if there may be a link
between NleH and ERK/MAPK pathways, some of which might
also alter RPS3 function [38,39].
Despite the significant sequence identity among NleH1, NleH2
and OspG, a protein kinase which blocks degradation of IkBa [26]
NleH1 or NleH2 did not appear to have the ability to alter IkBa
degradation or to interact with the host ubiquitin machinery.
However, it remains to be determined if NleH might associate
with other E2 enzymes not studied in our assays. Notably, unlike
NleH1 and NleH2, OspG does not possess the N-terminal region
responsible for binding to RPS3, which might explain its
differential activities and host targets.
Previous studies have elegantly shown that while A/E pathogens
induce host IL-8 expression through both MAPK and TLR5-
dependent activation of NF-kB, translocated effectors also down-
regulate IL-8 at early stages of infection [20,21]. However, only
traditional NF-kB Rel proteins have been characterized in these
studies. It is significant that these Rel proteins are associated with
only ,60% of canonical- or related-kB sites [60]. Thus, additional
regulatory components, including RPS3, may contribute to high
affinity DNA binding at various promoters [18]. Our results
suggest that NleH1, but not NleH2, down-regulates NF-kB
activity at RPS3-dependent, but not RPS-independent promoters.
We propose that NleH1-reduction of RPS3 nuclear abundance in
response to PAMP detection may explain previously documented
findings that IL-8 expression is suppressed at early stages of
infection, even in the context of NF-kB Rel protein nuclear
translocation and increased DNA-binding activity [20,21,22,23].
A Shigella OspG homolog in EHEC strain 11128 of E. coli
serogroup O111 was recently described as a translocated effector
[61]. This protein is somewhat distantly related (,30% identity) to
NleH1 or NleH2 and lacks the N-terminal domain of NleH that is
responsible for binding to RPS3. In this work, EHEC OspG was
not found to inhibit significantly NF-kB activity. These authors
showed that an EHEC T3SS effector, but not OspG, inhibited
p65 nuclear translocation and E. coli strain 13369 altered IkBa
degradation at 1 h post-infection. It was also previously shown that
NleH2, rather than NleH1, is encoded by EHEC strains of the
O111 serotype [62]. As we have shown that NleH1, but not
NleH2, inhibits the contribution of RPS3 to NF-kB activity, it is
perhaps not surprising that inhibition of NF-kB was not observed
in the O111 strains recently examined [61]. Consistent with these
studies [61], we also failed to observe a role for NleH in inhibiting
p65 nuclear translocation. However, our analysis of NleH is
limited to RPS3-dependent kB promoters and we consider it likely
that other T3SS effectors will be discovered to inhibit NF-kB
through other mechanisms.
While we did not observe NleH2 to inhibit RPS3 function, it
may influence NF-kB through an alternative mechanism or affect
other host signal transduction networks. Interestingly, NleH2
increased the activity of an AP-1-dependent luciferase reporter.
EHEC infection has been shown to induce the phosphorylation of
multiple MAPKs, including ERK1/2, p38, and JNK, which in
turn induce AP-1 activation at later stages of infection [63]. There
are multiple transcription factor binding sites in the IL-8
promoter, including both AP-1 and NF-kB [64]. NleH1 and
NleH2 may potentially target different host signal transduction
pathways to contribute to the suppression of host innate responses
to infection.
It was previously reported that an ‘espG/orf3Dcore’ EPEC
mutant deficient in ‘EspG/Orf3/EspH/CesF/Map/CesT/Tir/
Intimin’ did not differ from wild-type EPEC in its ability to inhibit
IL-8 secretion from Caco-2 cells [20]. Because this mutant also
lacked the chaperone CesT, it was predicted to be deficient in
translocation of other effectors, including NleH [20,65]. Thus, it
was postulated that inhibition of IL-8 secretion might be due to a
different non-LEE T3SS-dependent effector [20]. However, others
reported that deletion of nleH in C. rodentium reduced TNF-a
expression in infected mice, as compared with wild-type C.
rodentium infection [25]. These contrasting results may also be a
function of the different assay systems, cell types, and animal
models employed. For example, it has been reported that the in
vivo effect of NleH may be variable with respect to the host animal
under investigation [25]. Deleting both nleH1 and nleH2 from
E. coli O157:H7 caused increased shedding compared with the
parental strain in Friesian bull calves, yet had a reduced
competitive advantage in mixed infections of lambs [25].
Our analysis of EHEC strains deleted for nleH1 and nleH2 in
gnotobiotic piglets support a role for NleH1 in modulating the host
innate response to infection. Previous studies have reported that
severe HUS correlates with increased inflammation induced by
STEC infection [66]. Chemokines produced in response to
bacterial PAMPs have been reported to lead to the stimulation
and subsequent basolateral-to-apical transmigration of neutro-
phils, inducing concomitant translocation of Shiga-like toxins in
the opposite direction [67]. Shiga toxin attachment to monocytes
and macrophages can stimulate TNF-a, IL-1 and IL-6 secretion,
subsequently increasing globotriaosylceramide (Gb3) expression
on endothelial cell membranes [68]. Intimin-negative STEC that
lack the LEE (and thus are unlikely to translocate Nles) induce
higher neutrophil migration and higher IL-8 secretion compared
with intimin-positive STEC [67]. It should be noted that the
primary cause of death in the gnotobiotic piglet model we
employed is a manifestation of systemic intoxication, rather than
diarrheal disease. As deleting nleH1 relieved the inhibition of NF-
kB-dependent IL-8 gene expression in our in vitro assays, it is
possible that deleting nleH1 could lead to greater neutrophil
activation and Stx influx into the circulatory system.
Our findings suggest a novel mechanism for bacterial
manipulation of the host response and demonstrate the direct
binding of a bacterial effector to an NF-kB subunit. NF-kBi sa
major regulator of not only acute antimicrobial responses, but also
adaptive immune responses. A growing number of cellular factors
that govern the selective binding of NF-kB to different promoters
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effectors [6,7], provide us with significant opportunity to
understand how pathogens subvert the host response to infection.
Materials and Methods
Ethics statement
All animal experiments were performed according to Institu-
tional Animal Care and Use Committee-approved protocols
(Animal Welfare Assurance no. A3958-01).
Materials
The TEM-1 fusion cloning vector pCX340 was a generous gift
from E. Oswald. Chemicals were used according to manufactur-
ers’ recommendations and were obtained from Sigma, except for
the following: myelin basic protein (New England Biolabs), Erk1
kinase (Cell Signaling), QuikChange Site-Directed Mutagenesis
Kit (Stratagene), Dual-Luciferase Reporter Assay System (Pro-
mega), CCF2-AM Loading Kit (Invitrogen), Ni-NTA agarose
(Qiagen), protein G agarose (Fisher), TNF-a (Genscript), RPS3
siRNA (Santa Cruz Biotechnology), and FuGene (Roche).
Antibodies were obtained from the following sources: calnexin,
His, FLAG, HA, b-actin, and tubulin (Sigma), phospho-Ser/Thr
(Abcam), RPS3 (PrimmBiotech Inc.), RPS16 (Abnova), TEM
(QED bioscience), p50/p105, p65, IkBa ubiquitin (Genscript),
PARP (BD Biosciences), and phospho-IkBa (Cell Signaling).
Bacterial strains, plasmids, and oligonucleotides
Thebacterial strainsandplasmidsused inthisstudyaredescribed
in Table 1. The oligonucleotides used in this study are described in
Table 2. The deletion of individual nleH1 and nleH2 genes, and the
construction of a DnleH1DnleH2 mutant was performed using
lambda Red-mediated mutagenesis [41] in E. coli O157:H7
EDL933 by replacing nleH1 and/or nleH2 with a kanamycin
resistance marker, using plasmid pKD46 to generate the deletion
cassettes. Gene replacements were confirmed with multiple PCRs
andbyRT-PCR.Thebacterialgrowthkinetics,bacterialadherence
to host cells, and Tir translocation into host cells did not differ
significantly among nleH mutants and the parental strains.
Effector translocation assays
NleH-TEM fusions were constructed by cloning nleH1 and nleH2
into pCX340. For assaying NleH-TEM translocation, plasmids
were introduced into wild type and DescN EPEC and used to infect
HeLa cells for 4 h in DMEM supplemented with 1 mM IPTG.
Cells were washed and loaded with CCF2/AM. Fluorescence was
evaluated after cells were illuminated at 409 nm [30]. NleH-FLAG
fusions were constructed by cloning nleH1 and nleH2 into pFLAG-
CTC (Sigma). HeLa cell monolayers were infected with EPEC
strains (MOI ,100) for 4 h, washed, trypsinized, and resuspended
in homogenization buffer (3 mM imidazole [pH 7.4], 250 mM
sucrose, 0.5 mM EDTA). Cells were mechanically disrupted by
vigorous passage through 22- and 27-gauge needles. Low-speed
centrifugation (3,000 g,159)wasapplied tothe homogenatetopellet
the bacteria, unbroken HeLa cells, host nuclei, and cytoskeletal
components. The supernatant was then subjected to ultracentrifu-
gation (100,000 g, 1 h) to separate insoluble host cell membranes
from soluble cytosolic proteins [24]. The resulting fractions were
resolved by SDS-PAGE (10% polyacrylamide) and transferred to
nitrocellulose for Western blot analysis.
Protein purification
nleH1 and nleH2 were cloned into pET-28a and expressed in E.
coli BL21(DE3). 250 ml of bacterial culture were grown to an
OD600 of 0.6, when IPTG was added to 1 mM. After 4 h
additional growth, cells were pelleted and resuspended in 25 ml
cold PBS. Cells were sonicated and centrifuged to clarify the
supernatant. The supernatant was added to pre-equilibrated
Ni-NTA agarose and incubated for 2 h. The slurry was washed
5 times with 60 mM imidazole, 500 mM NaCl, 20 mM Tris HCl
pH 7.9, eluted in 1 M imidazole, 1 M NaCl, 40 mM Tris HCl
pH 7.9, and analyzed on 12% SDS-PAGE.
Affinity columns
Thirty confluent 150 mM dishes of HeLa cells were washed
with PBS and lysed in 20 ml of binding buffer [150 mM NaCl,
20 mM Tris (pH 8.0), 1% Triton X-100]. After centrifugation
(5,000 g, 4uC, 109), 10 ml of the supernatant was transferred to a
15 ml conical tube containing 300 ml Ni-NTA agarose in the
presence or absence of 500 mg purified His-NleH1. After
incubation for 1 h at 4uC, the columns were washed with binding
buffer and then eluted with increasing concentrations of imidazole
(0–300 mM). Fractions were analyzed by SDS-PAGE and staining
with Coomassie Blue G-250.
Protein identification by LC-ESI-MS/MS
Bands excised from protein gels were digested in-gel with
trypsin at 37uC overnight. The tryptic peptide solution was
transferred to a microcentrifuge tube, extracted with 1% formic
acid, 2% acetonitrile in water, followed by extraction with 50%
acetonitrile. Both extracts were combined, concentrated, and
suspended in 3% acetonitrile, 0.1% formic acid. Peptide analysis
was performed using LC-ESIMS/MS. Peptides were desalted in-
line and concentrated with RP-Trap Symmetry300 C18 column,
5 mm NanoEase (Waters), and separated using a C18 RP PepMap
capillary column on a CapLC (Dionex). The eluted ions were
analyzed by one full precursor MS scan (400–1500 m/z), followed
by four MS/MS scans of the most abundant ions detected in the
MS scan. Spectra were obtained in the positive ion mode with a
nano ESI-Q-Tof micro mass spectrometer (Micromass). A peak list
(PKL format) was generated to identify +1 or multiple charged
precursor ions from the mass spectrometry data file. Mascot server
v2.2 (www.matrix-science.com) in MS/MS ion search mode was
applied to conduct peptide matches (peptide masses and sequence
tags) and protein searches against NCBInr v20080110.
Immunoprecipitation and immunoblotting
Bacterial strains were grown in Luria–Bertani (LB) broth, at
37uCi n5 %C O 2 without shaking. HeLa cells were grown in
Dulbecco’s minimal Eagle medium (DMEM) supplemented with
10% heat-inactivated fetal calf serum (FCS). Cell culture media
was replaced with DMEM 3 h prior to infection. Overnight
bacterial cultures were diluted 1:10 into DMEM, incubated 3 h at
37uCi n5 %C O 2 (to ‘pre-activate’ the T3SS; [72]) and used to
infect two 150 mm dishes of ,80% confluent HeLa cells at a
multiplicity of infection of ,50. Cells were harvested after a 4 h
infection by washing them 3 times with PBS to remove bacteria.
Cells were scraped into PBS, pooled, centrifuged (1,500 g, 59),
resuspended in PBS, and recentrifuged. The supernatant was
removed and cells were lysed in RIPA [150 mM NaCl, 50 mM
Tris pH 8.0, 0.4 mM EDTA, 10% glycerol, 1% Nonident P-40
(NP-40)], followed by brief vortexing and rotation for 309 at 4uC.
The supernatant was transferred to a tube containing protein G
sepharose (prewashed in RIPA) and incubated for 1 h at 4uC.
Samples were centrifuged (1,500 g, 59), transferred to prewashed
a-FLAG resin, and incubated with rotation overnight at 4uC.
FLAG resin was washed with RIPA and resuspended in 500 ml
RIPA (without NP-40). The resin was centrifuged (2,000 g, 59) and
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Strain or plasmid Description Reference
Strains
Escherichia coli BL21(DE3) E. coli F
- ompT hsdSB (rB
-mB
-) gal dcm (DE3) Novagen
BL21(DE3)/pNleH1-pET28a His-NleH1 This study
BL21(DE3)/pNleH2-pET28a His-NleH2 This study
BL21(DE3)/pNleH1(K159A)-pET28a His-NleH1 K159A mutant This study
BL21(DE3)/pNleH2(K169A)-pET28a His-NleH2 K169A mutant This study
EPEC E2348/69 wild type E. coli O127:H6 isolate [73]
E2348/69DescN EPEC T3SS mutant [74]
E2348/69/pNleH1-FLAG EPEC expressing NleH1-FLAG This study
E2348/69 DescN/pNleH1-FLAG T3SS EPEC expressing NleH1-FLAG This study
E2348/69/pNleH2-FLAG EPEC expressing NleH2-FLAG This study
E2348/69 DescN/pNleH2-FLAG T3SS EPEC expressing NleH2-FLAG This study
E2348/69/pNleH1-TEM EPEC expressing NleH1-TEM This study
E2348/69 DescN/pNleH1-TEM T3SS EPEC expressing NleH1-TEM This study
E2348/69/pNleH2-TEM EPEC expressing NleH2-TEM This study
E2348/69 DescN/pNleH2-TEM T3SS EPEC expressing NleH2-TEM This study
E2348/69/pNleH1(K159A)-TEM EPEC expressing NleH1(K159A)-TEM This study
E2348/69 DescN/pNleH1(K159A)-TEM T3SS EPEC expressing NleH1(K159A)-TEM This study
E2348/69/pNleH2(K169A)-TEM EPEC expressing NleH2(K169A)-TEM This study
E2348/69 DescN/pNleH2(K169A)-TEM T3SS EPEC expressing NleH2(K169A)-TEM This study
E2348/69/pTEM EPEC expressing TEM This study
E2348/69 DescN/pTEM T3SS EPEC expressing TEM This study
EPEC UMD207 EPEC bfp-eae- [75]
EPEC UMD207/pNleH1-FLAG UMD207 expressing NleH1-FLAG This study
EPEC UMD207/pNleH2-FLAG UMD207 expressing NleH2-FLAG This study
EPEC UMD207/pNleH1(K159A)-FLAG UMD207 expressing NleH1(K159A)-FLAG This study
EPEC UMD207/pNleH2(K169A)-FLAG UMD207 expressing NleH2(K169A)-FLAG This study
EPEC UMD207/pFLAG UMD207 expressing FLAG This study
EPEC UMD207/pnleF-FLAG UMD207 expressing NleF-FLAG [9]
EHEC EDL933 wild type E. coli O157:H7 isolate CDC
EDL933 DescN EHEC T3SS mutant J. Puente
EDL933 DnleH1 EHEC nleH1 deletion This study
EDL933 DnleH2 EHEC nleH2 deletion This study
EDL933 DnleH1DnleH2 EHEC nleH1nleH2 deletion This study
EDL933/pNleH1-FLAG EHEC expressing NleH1-FLAG This study
EDL933/pNleH2-FLAG EHEC expressing NleH2-FLAG This study
EDL933/pFLAG EHEC expressing FLAG This study
EDL933 DnleH1/pNleH1-FLAG EHEC nleH1 deletion expressing NleH1-FLAG This study
EDL933 DnleH2/pNleH2-FLAG EHEC nleH2 deletion expressing NleH2-FLAG This study
EDL933 DnleH1/pNleH1-FLAG(K159A) EHEC nleH1 deletion expressing NleH1(K159A)-FLAG This study
EDL933 DnleH2/pNleH2-FLAG(K169A) EHEC nleH2 deletion expressing NleH2(K169A)-FLAG This study
Plasmids
pCX340 TEM-1 reporter plasmid [30]
NleH1-TEM NleH1-TEM This study
NleH2-TEM NleH2-TEM This study
pET28a Bacterial hexahistidine fusion expression Novagen
NleH1-pET28a His-NleH1 This study
NleH2-pET28a His-NleH2 This study
NleH1(K159A)-pET28a His-NleH1 K159A mutant This study
NleH2(K169A)-pET28a His-NleH2 K169A mutant This study
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FLAG and associated proteins were eluted from the resin by
adding 72 mg FLAG peptide (in 200 ml RIPA) and incubating with
rotation for 1 h at 4uC. The resin was centrifuged (2,000 g, 59),
and the supernatant was transferred to a fresh tube, precipitated
with trichloroacetic acid (TCA), and resuspended in SDS-PAGE
buffer. IP samples were interrogated for the presence of NleH-
FLAG and RPS3 by Western blotting.
Equal amounts of protein from cell lysates (50 mg) and IPs (5 mg)
were separated by SDS-PAGE, transferred to nitrocellulose,
blocked in Odyssey blocking buffer, double-probed overnight
with mouse-a-FLAG and rabbit-a-RPS3 1u antibodies, washed in
PBS, and then incubated for 309 with Alexa Fluor 680/750 goat-
a-rabbit and goat-a-mouse 2u antibodies at room temperature.
After rinsing in PBS, blots were imaged with an Odyssey infrared
imaging system (Li-Cor). For immunoprecipitation experiments
with transfected RPS3 and NleH plasmids, 293T cells were
incubated in 6-well plates and transfected with 1 mg total plasmid
using FuGene.
Bimolecular fluorescence complementation
HeLa cells were cultured in DMEM supplemented with 10%
FCS and co-transfected with a pair of BiFC plasmids (100–250 ng
each) representing NleH and RPS3 truncations cloned as fusions
to the N- or C-terminus of Venus eYFP (designated VN and VC).
The fluorescence intensities derived from BiFC (due to effector-
host protein binding) were measured after 48 h incubation using
appropriate filters (excitation: 500/20 nm; emission: 535/30 nm).
Strain or plasmid Description Reference
pFLAG-CTC Bacterial FLAG fusion protein expression Sigma
NleH1-pFLAG-CTC NleH1-FLAG This study
NleH2-pFLAG-CTC NleH2-FLAG This study
NleH1(K159A)-pFLAG-CTC NleH1(K159A)-FLAG This study
NleH2 (K169A)-pFLAG-CTC NleH2(K169A)-FLAG This study
NleF-pFLAG-CTC NleF-FLAG [9]
p3XFLAG Mammalian FLAG fusion expression Sigma
RPS3-p3XFLAG FLAG-RPS3 [18]
RPS3(1-101)-p3XFLAG FLAG RPS3 (AAs 1–101) [18]
RPS3(DKH)-p3XFLAG FLAG RPS3 (lacking KH domain AAs 41–111) [18]
RPS3(41-243)-p3XFLAG FLAG RPS3 (AAs 41–243) [18]
RPS3(112-243)-p3XFLAG FLAG RPS3 (AAs 112–243) [18]
kB (5X)-luc Firefly luciferase driven by RPS3/NF-kB-dependent kB site Promega
pTKRL-luc Renilla luciferase Promega
IL-2R-luc Firefly luciferase driven by IL-2R promoter [18]
CD25-luc Firefly luciferase driven by CD25-promoter [18]
AP-1-luc Firefly luciferase driven by AP-1-promoter [18]
pKD46 Lambda Red mediated mutagenesis [41]
VN Venus fluorescence protein (AAs 1–173) [76]
VC Venus fluorescence protein (AAs 155–238) [76]
VN-actin Venus 1–173 fused to human actin [76]
VC-actin Venus 155–238 fused to human actin [76]
VN-NleH1 Venus 1–173 fused to NleH1 This study
VC-NleH1 Venus 155–238 fused to NleH1 This study
VN-NleH2 Venus 1–173 fused to NleH2 This study
VC-NleH2 Venus 155–238 fused to NleH2 This study
VN-RPS3 Venus 1–173 fused to RPS3 This study
VC-RPS3 Venus 155–238 fused to RPS3 This study
VN-NleH1(1–129) Venus 1–173 fused to NleH1 AAs 1–129AA This study
VN-NleH1(130–293) Venus 1–173 fused to NleH1 AAs 130–293 AA This study
VN-NleH2(1–139) Venus 1–173 fused to NleH2 AAs 1–139AA This study
VN-NleH2(140–303) Venus 1–173 fused to NleH2 AAs 140–303 This study
VN-Citro-NleH Venus 1–173 fused to C. rodentium NleH This study
VN-NleH1(Y5S) Venus 1–173 fused to NleH1(Y5S) This study
VN-NleH1(N40S,A42T,K45T) Venus 1–173 fused to NleH1(N40S,A42T,K45T) This study
VN-NleH1 (A100T,A101T,M102I,I106S) Venus 1–173 fused to NleH1(A100T,A101T,M102I,I106S) This study
doi:10.1371/journal.ppat.1000708.t001
Table 1. Cont.
NleH Binds Ribosomal Protein S3
PLoS Pathogens | www.plospathogens.org 14 December 2009 | Volume 5 | Issue 12 | e1000708Table 2. Oligonucleotides used in this study.
Primer Sequence (59-39)



















































NleH Binds Ribosomal Protein S3
PLoS Pathogens | www.plospathogens.org 15 December 2009 | Volume 5 | Issue 12 | e1000708Immunofluorescence microscopy
HeLa and 293T cells were grown on glass coverslips in 24-well
tissue culture plates and infected for 4 h with overnight cultures of
indicated bacterial strains (MOI,20–50). After infection, cells were
washed 3 times in PBS containing Ca
2+/Mg
2+ and fixed in 2.5%
paraformaldehyde. Cells were permeabilized in 0.1% saponin in
PBS, blocked with 5% goat serum, and incubated with a-FLAG
(1:1,000), and a-RPS3 (1:200) primary antibodies for 1 h at room
temperature. The cells were washed with PBS and probed with
Alexa Fluor 488- and 594-conjugated secondary antibodies
(1:1,000, 1 h) and DAPI (1 mg/ml, 29). For experiments involving
transfection, 1 mg total plasmid suspended in Fugene was used and
cells were typically immunostained 48 h post-transfection. Cover-
slips were mounted in Mowiol and samples were visualized using a
LSM 510 Laser Scanning Microscope (Carl Zeiss).
In vitro kinase assays
Kinase assays were performed by incubating His-NleH proteins
(10 ng/ml) with myelin basic protein (MBP, 100 ng/ml) in 50 mM
Tris-HCl, pH 7.6, 5 mM MgCl2, 1 mM DTT, 1 mM ATP, at
30uC for 1 h. Phosphorylation was monitored by separating the
samples by SDS-PAGE and Western blotting with an a-phospho-
Ser/Thr-specific antibody [40] and Pro-Q staining. As a positive
control in the assay, ERK1 was used at a concentration of 5 ng/ml,
as it is known to phosphorylate MBP [38].
RPS3 nuclear translocation
Cytosolic and nuclear protein extracts were prepared from
HeLa or 293T cells transfected with NleH plasmids or infected
with nleH mutants as previously described [18]. TNF-a stimulation
(1 h, 100 ng/ml) was used to promote RPS3 translocation into the
nucleus. Data were analyzed by Western blotting for nuclear
RPS3. PARP and tubulin were used to normalize the protein
concentrations of nuclear and cytoplasmic fractions, respectively.
Luciferase assays
HeLa or 293T cells were co-transfected at a ratio of 10:1 (1.0 mg
total DNA) with a firefly luciferase construct driven by a consensus
kB site, together with the renilla luciferase pTKRL plasmid
(Promega), cultured for 36–48 h, and then infected with EHEC
strains for 3 h, in the presence or absence of TNF-a stimulation
(kB, CD25, IL-2R reporters) or PMA (AP-1 reporter) or silencing
with rps3 siRNA. Cells were lysed with passive lysis buffer and
lysates were analyzed by using the Dual-Luciferase Kit (Promega)
with firefly fluorescence units (FU) normalized to renilla FU. The
fold-induction was calculated as [relative FU stimulated)/(relative
FU unstimulated] samples. Luciferase assays were performed
in triplicate with at least three independently transfected cell
populations.
RT-PCR
cDNA was prepared from 1 mg RNA by using the Superscript
First Strand System (Invitrogen) with oligo (dT) primer. Real-time
PCR was performed in triplicate using a SYBR Green PCR
Master Mix (Ambion) in a Fast 7500 sequence-detection system
(Applied Biosystems). Relative transcription levels were calculated
by using the DDCt method.
Gnotobiotic piglet infections
Gnotobiotic piglets were delivered into germ-free incubators
through sterile closed hysterotomy of pregnant sows. Piglets were
separated into individual compartments without regard to sex, fed
individually with a sterile commercial piglet formula (SPF-Lac;
PetAg, Inc.), and inoculated at 24 h of age with 3 ml tryptic soy
broth containing 1*10
8 CFUs of wild type, DnleH1,o rD nleH2 E.
coli O157:H7 EDL933. Piglets were observed every 4 h for signs of
diarrhea, dehydration, and neurological signs of disease (head tilt,
circling, lethargy, inability to stand, lateral recumbency and
paddling). When piglets developed severe dehydration, lethargy or
CNS disease, they were euthanized and subjected to postmortem
examination. Animals that did not become lethargic or dehydrated
were euthanized after 8 d. Spiral colon specimens were collected
at necropsy, split longitudinally, rinsed in PBS to remove feces,
diluted 1:10 (w/v) in PBS, ground, normalized to tissue weight,
serially diluted, and cultured to quantify the extent of intestinal
colonization. Data were normalized by tissue weight.
Statistical analyses
NleH translocation, BiFC, RPS3 immunoblotting, luciferase,
and RT-PCR assays were analyzed statistically using one-way
ANOVA. RPS3 immunofluorescence data were analyzed with
t-tests. Gnotobiotic piglet data were analyzed with the Kruskal-
Wallis Test. p-values,0.05 were considered significant.
Supporting Information
Figure S1 NleH amino acid sequences and T3SS-dependent
translocation. A. E. coli EDL933 NleH1 (Z0989) and NleH2
(Z6021) amino acid sequences. Asterisks indicate identical
residues. Amino acids differing between NleH1 and NleH2 are
indicated in red. The lysine residue implicated in autopho-
sphorylation activity is depicted in blue. B. Immunoblotting of
bacterial lysates for NleH1- and NleH2-TEM expression in wild
type (wt) or T3SS-deficient DescN EPEC (T3SS). Blots were
probed with a-TEM antibody. C. b-lactamase activity (arbitrary
units) in HeLa cells loaded with CCF2/AM substrate and infected
for 4 h with wt or DescN EPEC (T3SS) strains expressing NleH1-
or NleH2-TEM fusions. Asterisks indicate significantly different
b-lactamase activity compared with uninfected samples (p,0.05,
ANOVA). D. Immunoblot analysis of cytoplasmic and membrane
HeLa cell fractions following infection with EPEC strains
expressing NleH1- or NleH2-FLAG. Blots were probed with
a-FLAG, a-tubulin, and a-calnexin antibodies.
Found at: doi:10.1371/journal.ppat.1000708.s001 (0.46 MB PDF)
Figure S2 Binding specificity of NleH. A. Affinity enrichment of
HeLa proteins with affinity for His-NleH1. HeLa cell lysates were
incubated with purified His-NleH1 pre-bound to Ni-NTA agarose,
eluted with imidazole, and analyzed by SDS-PAGE. Samples
included HeLa lysate + His-NleH1 (lane 1), His-NleH1 (lane 2),
and HeLa lysate (lane 3). Bands identified by mass spectrometry as
NleH1 and RPS3 are indicated. B. NleH does not bind RPS16.
HeLa cells were infected with EPEC expressing NleH1-FLAG and
immunoprecipitated with a-RPS3 (left) or a-RPS16 (right)
antibodies. The top and middle panels depict the abundance of
RPS3 and RPS16 in the cell lysate, whereas the bottom panel
depicts an a-FLAG immunoblot of the immunoprecipitated
samples. Similar results were obtained with NleH2-FLAG. C.
NleF does not bind RPS3. HeLa cells were infected with EPEC
expressing FLAG (left) or NleF-FLAG (right) and immunoprecip-
itated with a-RPS3 antibody. The top panel depicts RPS3 in the
cell lysates whereas the middle and bottom panels depict samples
immunoprecipitated with a-FLAG antibody and subsequently
immunoblotted for FLAG and RPS3, respectively.
Found at: doi:10.1371/journal.ppat.1000708.s002 (1.56 MB PDF)
Figure S3 NleH1 and NleH2 are autophosphorylated Ser/Thr
protein kinases. A. Autophosphorylation assay of His-NleH1 and
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NleH2(K169A). Blots were stained with Pro-Q. B. Phosphoryla-
tion of myelin basic protein (MBP) by wild-type NleH1 and
NleH2, but not the site-directed mutants NleH1(K159A) and
NleH2(K169A). Blots were probed with a-His and a-phospho-
Ser/Thr antibodies.
Found at: doi:10.1371/journal.ppat.1000708.s003 (0.38 MB PDF)
Figure S4 T3SS effector(s) inhibit RPS3 nuclear translocation.
A. Immunofluorescence microscopy analysis of RPS3 nuclear
abundance in HeLa cells infected with wild type (wt) or DescN
EHEC. B. Quantification of the % of cells containing predom-
inantly nuclear RPS3 (n=100 cells). Asterisks indicate significantly
different compared with wild-type infection (p,0.05, t-test).
Found at: doi:10.1371/journal.ppat.1000708.s004 (0.95 MB PDF)
Figure S5 NleH1 reduces the nuclear abundance of RPS3. A.
Quantification (n=4) of the fold-increase in nuclear p65 as
assessed from immunoblotting (depicted in Figure 5A), in the
absence (open bars) or presence (black bars) of TNF-a stimulation.
p65 signal intensity was normalized to PARP. B. Immunofluores-
cence microscopy analysis of NleH and RPS3 localization as a
function of TNF-a stimulation. HeLa cells were infected for 3 h
with EPEC strains expressing NleH1- or NleH2-FLAG, treated
with TNF-a (100 ng/ml) for 1 h, and stained with DAPI (blue), a-
FLAG (green), and a-RPS3 (red) monoclonal antibodies. C.
Immunoprecipitation of nuclear extracts with a-p65 antibody.
Immunoprecipitated samples were immunoblotted for p65 and
RPS3 in samples transfected with the indicated plasmids, in the
absence or presence of TNF-a stimulation. The numbers below
the gel indicate the relative RPS3 signal intensity (normalized to
PARP). D. Immunoprecipitation of RPS3 with C. rodentium
NleH and EHEC NleH1 site-directed mutants. 293T cells were
transfected with the indicated plasmids for 48 h and immunopre-
cipitated with an a-HA antibody. Immunoprecipitated samples
were immunoblotted for RPS3 and HA. The top panel indicates
immunoprecipitated RPS3 as a function of plasmid transfection
(N.S. is a non-specific band, used for normalization of sample
loading). The middle and bottom panels indicate RPS3 and HA
abundance in the cell lysates, respectively.
Found at: doi:10.1371/journal.ppat.1000708.s005 (4.28 MB PDF)
Figure S6 Differential impact of NleH1 and NleH2 on NF-kB
activity. A. Immunoblot analysis of RPS3 abundance after siRNA
treatment. The numbers below the gel indicate the relative RPS3
signal intensity after normalization to tubulin. B. NF-kB activity
(% activity compared to untreated samples) as a function of
transfection with rps3 siRNA (open squares) and non-specific
siRNA (closed squares). C. NF-kB activity as a function of
transfection with RPS3-FLAG, in the presence of co-transfected
HA (open circles), NleH1-HA (open squares), or NleH2-HA
(closed squares). D. NF-kB activity as a function of transfection
with HA (open circles), NleH1-HA (open squares), or NleH2-HA
(closed squares).
Found at: doi:10.1371/journal.ppat.1000708.s006 (0.35 MB PDF)
Figure S7 Sequence alignment of NleH and OspG from STEC,
C. rodentium, and S. flexneri. Homologous protein sequences were
aligned by using ClustalW. Black box indicates the region of
NleH1 interacting with RPS3. The symbols indicate the residues
that were studied for their contribution to NleH1-mediated
inhibition of RPS3/NF-kB activity (D, significant inhibition; *,
partial inhibition; #, no inhibition). Coloring is used to highlight
the sequence conservation of these residues among NleH proteins
encoded by the indicated bacterial strains.
Found at: doi:10.1371/journal.ppat.1000708.s007 (0.27 MB PDF)
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